Citius Oncology (CTOR) Non Operating Income (2023 - 2026)
Citius Oncology (CTOR) posted quarterly Non Operating Income of $1.8 million for Q1 2026, up 10199.07% quarter-over-quarter from -$17553.0 in Q4 2025.
Citius Oncology (CTOR) Non Operating Income (2023 - 2026) Analysis & Trends
Citius Oncology (CTOR) has reported Non Operating Income for 4 consecutive years, with $1.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non Operating Income changed N/A year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $3.1 million (changed N/A YoY), while the FY2025 annual figure was -$181659.0, changed N/A from the prior year.
- Non Operating Income climbed to $1.8 million in Q1 2026 per CTOR's latest filing, from -$17553.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $2.2 million in Q3 2023 and bottomed at -$17553.0 in Q4 2025.
- Historically, Non Operating Income has averaged $982886.6 across 4 years, with a median of $759647.0 in 2023.
- On a YoY basis, Non Operating Income climbed as much as 0.18% in 2024 and fell as far as 21.99% in 2024.
- Citius Oncology's Non Operating Income stood at $2.2 million in 2023, then tumbled by 70.47% to $636419.0 in 2024, then plunged by 102.76% to -$17553.0 in 2025, then jumped by 10199.07% to $1.8 million in 2026.
- Business Quant data shows CTOR's Non Operating Income at $1.8 million in Q1 2026, -$17553.0 in Q4 2025, and $636419.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Citius Oncology | 76.95 Mn | 76.95 Mn | 1.00 Mn | -314,376.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.77 Mn |
| Dec 31, 2025 | -17,553.00 |
| Jun 30, 2024 | 636,419.00 |
| Mar 31, 2024 | 758,258.00 |
| Sep 30, 2023 | 2.15 Mn |
| Jun 30, 2023 | 815,850.00 |
| Mar 31, 2023 | 759,647.00 |